133 related articles for article (PubMed ID: 10755204)
1. Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.
Tanimura M; Mishima T; Steinberg MI; Borzak S; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2000 Feb; 14(1):77-82. PubMed ID: 10755204
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
Sabbah HN; Levine TB; Gheorghiade M; Kono T; Goldstein S
Cardiovasc Drugs Ther; 1993 Jun; 7(3):349-56. PubMed ID: 8395876
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure.
Adamson PB; Vanoli E; Mattera GG; Germany R; Gagnol JP; Carminati P; Schwartz PJ
J Cardiovasc Pharmacol; 2003 Aug; 42(2):169-73. PubMed ID: 12883318
[TBL] [Abstract][Full Text] [Related]
4. Divergent effects of intravenous dobutamine and nitroprusside on left atrial contribution to ventricular filling in dogs with chronic heart failure.
Kono T; Sabbah HN; Rosman H; Shimoyama H; Alam M; Goldstein S
Am Heart J; 1994 Apr; 127(4 Pt 1):874-80. PubMed ID: 8154426
[TBL] [Abstract][Full Text] [Related]
5. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
[TBL] [Abstract][Full Text] [Related]
6. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
[TBL] [Abstract][Full Text] [Related]
7. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
Shen W; Gill RM; Jones BD; Zhang JP; Corbly AK; Steinberg MI
J Pharmacol Exp Ther; 2002 Nov; 303(2):673-80. PubMed ID: 12388650
[TBL] [Abstract][Full Text] [Related]
8. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
[TBL] [Abstract][Full Text] [Related]
9. Sodium channel enhancer restores baroreflex sensitivity in conscious dogs with heart failure.
Shen W; Gill RM; Zhang JP; Jones BD; Corbly AK; Steinberg MI
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1508-14. PubMed ID: 15563539
[TBL] [Abstract][Full Text] [Related]
10. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure.
Sabbah HN; Imai M; Cowart D; Amato A; Carminati P; Gheorghiade M
Am J Cardiol; 2007 Jan; 99(2A):41A-46A. PubMed ID: 17239704
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with congestive heart failure.
Tisdale JE; Gheorghiade M
Am J Cardiol; 1992 Jun; 69(18):34G-47G. PubMed ID: 1626491
[TBL] [Abstract][Full Text] [Related]
13. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
14. Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure.
Asai K; Uechi M; Sato N; Shen W; Meguro T; Mathier MA; Shannon RP; Vatner SF
Am J Physiol; 1998 Dec; 275(6):H2219-26. PubMed ID: 9843822
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
Mak S; Overgaard CB; Newton GE
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2424-8. PubMed ID: 16040714
[TBL] [Abstract][Full Text] [Related]
16. Inotropic and lusitropic effects of incremental doses of dobutamine in dogs with right ventricular apical pacing-induced cardiac dysfunction.
Nakata TM; Kaji H; Matsuura N; Shimizu M; Tanaka R
J Vet Pharmacol Ther; 2019 May; 42(3):285-293. PubMed ID: 30724383
[TBL] [Abstract][Full Text] [Related]
17. A sodium channel enhancer, LY341311, increases myocardial contractile performance without increasing heart rate in conscious normal dogs: a comparison with dobutamine.
Gill RM; Jones BD; Steinberg MI; Shen W
J Card Fail; 2002 Feb; 8(1):33-42. PubMed ID: 11862581
[TBL] [Abstract][Full Text] [Related]
18. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
[TBL] [Abstract][Full Text] [Related]
19. Vitamin C augments the inotropic response to dobutamine in humans with normal left ventricular function.
Mak S; Newton GE
Circulation; 2001 Feb; 103(6):826-30. PubMed ID: 11171790
[TBL] [Abstract][Full Text] [Related]
20. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
Shinke T; Shite J; Takaoka H; Hata K; Inoue N; Yoshikawa R; Matsumoto H; Masai H; Watanabe S; Ozawa T; Otake H; Matsumoto D; Hirata K; Yokoyama M
Am Heart J; 2007 Oct; 154(4):645.e1-8. PubMed ID: 17892985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
